Compare DNLI & ABG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNLI | ABG |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.1B |
| IPO Year | 2017 | 2001 |
| Metric | DNLI | ABG |
|---|---|---|
| Price | $18.63 | $173.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 11 |
| Target Price | $35.75 | ★ $237.64 |
| AVG Volume (30 Days) | ★ 1.8M | 236.6K |
| Earning Date | 11-05-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.88 |
| EPS | N/A | ★ 16.20 |
| Revenue | N/A | ★ $17,999,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $158.26 | $4.13 |
| P/E Ratio | ★ N/A | $10.13 |
| Revenue Growth | N/A | ★ 4.71 |
| 52 Week Low | $13.75 | $160.30 |
| 52 Week High | $27.30 | $258.75 |
| Indicator | DNLI | ABG |
|---|---|---|
| Relative Strength Index (RSI) | 41.65 | 46.27 |
| Support Level | $18.07 | $160.30 |
| Resistance Level | $20.84 | $203.19 |
| Average True Range (ATR) | 0.82 | 5.85 |
| MACD | 0.09 | 1.64 |
| Stochastic Oscillator | 47.64 | 79.19 |
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
Asbury Automotive Group is a regional collection of automobile dealerships that went public in March 2002. The company operates 158 new-vehicle stores and 37 collision centers. Over 70% of new-vehicle revenue is from luxury and import brands. Asbury also offers third-party financing and insurance products and its own F&I products via Total Care Auto. Asbury operates in 14 states (mostly in Rocky Mountain states, Texas, the Northeast, and Southeast). Asbury store brands include Herb Chambers in the Northeast, McDavid and Park Place in Texas, Koons in the Washington, D.C., area, and the Larry H. Miller brand in the Western US. Asbury generated about $18 billion of revenue in 2025 and is based in the Atlanta area. The firm targets at least $30 billion of revenue sometime around 2030.